Gilead ’s Quad single tablet regimen for HIV non-inferior to Atripla® in pivotal Phase 3 study
7 March 2012 | By Gilead Sciences Inc
Quad currently under review for marketing approval...
List view / Grid view
News
Signifor® is first therapy to provide rapid, durable benefit for Cushing’s disease patients
7 March 2012 | By Novartis
A study found that the investigational drug Signifor®, normalized cortisol levels...
Tecan triumphs at SLAS2012 with Direct Digital Titration
6 March 2012 | By kdm communications limited
The First Annual SLAS Conference and Exhibition held in San Diego, California, in February heralded success for Tecan...
£10 million boost for neglected tropical disease research at Dundee
6 March 2012 | By University of Dundee
Dundee, GSK and Wellcome Trust enter five-year collaboration for neglected diseases...
Abbott and Merck collaborate to develop companion diagnostic test
6 March 2012 | By Abbott
Abbott will collaborate with Merck to evaluate the use of a FISH-based companion diagnostic test...
Regulatory Update: GSK announces submissions for two influenza vaccines
5 March 2012 | By GlaxoSmithKline
GSK has submitted regulatory files for two of its influenza vaccines currently in development...
Merck’s investigational AIT significantly reduced the combination of ragweed allergy symptoms and medication use in Phase III Trial
5 March 2012 | By Merck
Phase III clinical study results announced...
Composition of Sanofi’s Board of Directors
5 March 2012 | By Sanofi
At its meeting held on March 5, 2012, the Board of Directors of Sanofi decided to propose the appointment of a new director...
Abbott to collaborate on rapid molecular test to identify serious infections in bones and joint
5 March 2012 | By Abbott
Abbott announced it will collaborate with Genetics Laboratory, Inc. (GenLab)...
Merck provides U.S. regulatory update on investigational ezetimibe/atorvastatin tablets
5 March 2012 | By Merck
The U.S. FDA has issued a Complete Response Letter regarding Merck's NDA...
Sanofi demonstrates continued support for patient groups with launch of Patient Group Bursary 2012
5 March 2012 | By Just:: Health PR
Sanofi has signalled its continuing commitment to support patient groups in the UK with the launch of its 2012 Patient Group Bursary...
Chip-Man Technologies rebrands and launches new website
2 March 2012 | By kdm communications limited
Effective from 1st March 2012, Chip-Man Technologies will trade as CM Technologies...
Porcine circovirus research projects from France and Spain awarded
2 March 2012 | By Boehringer Ingelheim
The European PCV2 Research Award funds research projects related to PCV2 infection and associated diseases...
Abbott’s STARLIMS business acquires distribution partners to build international presence
2 March 2012 | By Abbott
STARLIMS Technologies announced the acquisition of longtime distribution partners...
Teva announces launch of generic Prometrium® Capsules in the US
2 March 2012 | By Teva Pharmaceutical Industries Ltd
Teva Pharmaceutical Industries Ltd. announced the commercial launch of Progesterone Capsules...
